Dr. Ian Gallaher
Claim this profileSaint James Community Hospital and Cancer Treatment Center
Studies Adenocarcinoma
Studies Cancer
5 reported clinical trials
18 drugs studied
Area of expertise
1Adenocarcinoma
2Cancer
Stage I
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Ian Gallaher is currently running
MRI Monitoring vs. Preventive Brain Radiation
for Small Cell Lung Cancer
This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients' lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread of the cancer) may be at least as good as the combination of PCI with MRI scans.
Recruiting2 awards Phase 322 criteria
Hormone Therapy + Radiation
for Prostate Cancer
This phase III trial uses the Decipher risk score to guide intensification (for higher Decipher gene risk) or de-intensification (for low Decipher gene risk) of treatment to better match therapies to an individual patient's cancer aggressiveness. The Decipher risk score evaluates a prostate cancer tumor for its potential for spreading. In patients with low risk scores, this trial compares radiation therapy alone to the usual treatment of radiation therapy and hormone therapy (androgen deprivation therapy). Radiation therapy uses high energy x-rays or particles to kill tumor cells and shrink tumors. Androgen deprivation therapy blocks the production or interferes with the action of male sex hormones such as testosterone, which plays a role in prostate cancer development. Giving radiation treatment alone may be the same as the usual approach in controlling the cancer and preventing it from spreading, while avoiding the side effects associated with hormonal therapy. In patients with higher Decipher gene risk, this trial compares the addition of darolutamide to usual treatment radiation therapy and hormone therapy, to usual treatment. Darolutamide blocks the actions of the androgens (e.g. testosterone) in the tumor cells and in the body. The addition of darolutamide to the usual treatment may better control the cancer and prevent it from spreading.
Recruiting2 awards Phase 31 criteria
More about Ian Gallaher
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ian Gallaher has experience with
- Intensity-Modulated Radiation Therapy (IMRT)
- Stereotactic Body Radiation Therapy (SBRT)
- Prophylactic Cranial Irradiation
- Magnetic Resonance Imaging
- Degarelix
- Histrelin
Breakdown of trials Ian Gallaher has run
Cancer
Prostate Cancer
Small Cell Lung Cancer
Small Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ian Gallaher specialize in?
Ian Gallaher focuses on Adenocarcinoma and Cancer. In particular, much of their work with Adenocarcinoma has involved treating patients, or patients who are undergoing treatment.
Is Ian Gallaher currently recruiting for clinical trials?
Yes, Ian Gallaher is currently recruiting for 2 clinical trials in Butte Montana. If you're interested in participating, you should apply.
Are there any treatments that Ian Gallaher has studied deeply?
Yes, Ian Gallaher has studied treatments such as Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), Prophylactic Cranial Irradiation.
What is the best way to schedule an appointment with Ian Gallaher?
Apply for one of the trials that Ian Gallaher is conducting.
What is the office address of Ian Gallaher?
The office of Ian Gallaher is located at: Saint James Community Hospital and Cancer Treatment Center, Butte, Montana 59701 United States. This is the address for their practice at the Saint James Community Hospital and Cancer Treatment Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.